1. Determination of effective half-life of 131I in thyroid cancer patients using remote dose-rate meter
- Author
-
Laura Kääriä, Maria Lapela, Marko Seppänen, Mikael Högerman, Johanna Ruohola, Annika Ålgars, and Tommi Noponen
- Subjects
131I ,Radioactive iodine ,Effective half-life ,Radiation safety ,Remote dose-rate meter ,Medical physics. Medical radiology. Nuclear medicine ,R895-920 - Abstract
Abstract Background Continuously monitored external dose-rate signals from remote dose-rate meters (DRMs) were analyzed to determine the effective half-life (Teff) of 131I in differentiated thyroid cancer (DTC) patients. The aim is to gain novel understanding of the excretion of radioactive iodine (RAI) in DTC patients and to demonstrate that a remote DRM system can be reliably used for real-time monitoring of external dose-rates of DTC patients. Methods 110 DTC patients who received postoperative RAI therapy between September 2018 and February 2023 in Turku University Hospital were studied retrospectively. The external dose-rates of the patients were continuously monitored during their hospitalization with a remote DRM fixed in the ceiling of the isolation room. Generalized linear mixed model (GLMM) was used to analyse the association between logarithmical Teff and patient characteristics. Results The median Teff for all patients was 12.60 h (Q1: 10.35; Q3: 14.75 h). Longer Teffs were associated with higher BMI (p = 0.004), lower GFR (p
- Published
- 2024
- Full Text
- View/download PDF